With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
News-Medical.Net on MSN
Minimal residual disease monitoring can transform breast cancer care
Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback